PIC Therapeutics Competitors and Similar CompaniesClear all
PIC Therapeutics's competitors and similar companies include Tizona Therapeutics, Monte Rosa Therapeutics, Actym Therapeutics and ALX Oncology.
 Tizona Therapeutics Tizona Therapeutics is harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. |  Monte Rosa Therapeutics Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways. |  ALX Oncology ALX Oncology is a company that develops protein-based therapeutics intended to help in cancer treatment. | |||
Founding Date | Founding Date 2018 | Founding Date 2014 | Founding Date 2018 | Founding Date 2017 | Founding Date 2015 |
Type | Type Private | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Natick, US HQ | Locations South San Francisco, US HQ | Locations Boston, US HQ Basel, CH Basel, CH Basel, CH Boston, US Cambridge, US | Locations Berkeley, US HQ | Locations Burlingame, US HQ Dublin 2, IE |
Employees | Employees 7 | Employees 24 | Employees 75 | Employees 11 | Employees 743% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 575.1 m | Valuation ($) N/A | Valuation ($) 77.5 m |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income ($38.6m) (FY, 2025) | Net income N/A | Net income ($101.7m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 5m (about 6 years ago) | Latest funding round $ 43m (about 10 years ago) | Latest funding round N/A | Latest funding round $ 34m (about 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 5m | Total funding raised $ 70m | Total funding raised $ 223.5m | Total funding raised $ 34m | Total funding raised $ 166m |
For sources of this data, please see the company profile
View Company Profiles
Tizona Therapeutics
HQ
South San Francisco, US
Employees
24
Tizona Therapeutics is harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases.
View companyMonte Rosa Therapeutics
HQ
Boston, US
Employees
75
Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways.
View company
Actym Therapeutics
HQ
Berkeley, US
Employees
11
Actym Therapeutics is a preclinical immuno-oncology company.
View companyALX Oncology
HQ
Burlingame, US
Employees
74↑ 3% increase
ALX Oncology is a company that develops protein-based therapeutics intended to help in cancer treatment.
View company